Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal bromocriptine vs dienogest for treatment of adenomyosis
IRCT20230407057838N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Oct 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bromocriptine and dienogest in adenomyosis (2 arms), sponsored by Iran University of Medical Sciences. Started Oct 2021; status: completed.
02
Drugs
bromocriptinedienogest
03
Conditions
adenomyosis
Beyond the preview
Go deeper on IRCT20230407057838N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230407057838N1.